Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (471-480 of 636) with videos related to

Pageof 64
Sort By:
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 2018
Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat rangeCharlie C Park, Catherine Hooker, Jonathan C Hooker, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2023
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLDBeom K Kim, Nicole Bernstein, Daniel Q Huang, et al.
Gastroenterology|March 11, 2026
Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseFasiha Kanwal, Fernando Bril, Vincent Wai-Sun Wong, et al.
Gastroenterology|October 4, 2021
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver DiseaseFasiha Kanwal, Jay H Shubrook, Leon A Adams, et al.
World Journal of Gastroenterology|August 14, 2025
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virusAna N Hyatt, Sai K Kuchana, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics|December 29, 2023
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United StatesSamer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, et al.
The Journal of Pediatrics|September 19, 2017
Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic BoysJulia Wattacheril, Joel E Lavine, Naga P Chalasani, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Pageof 64

Showing results (471-480 of 636) with videos related to

Sort By:
Pageof 64
Hepatology Communications|June 18, 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH StudyA Sidney Barritt, Stephanie Watkins, Norman Gitlin, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 2018
Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat rangeCharlie C Park, Catherine Hooker, Jonathan C Hooker, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2023
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLDBeom K Kim, Nicole Bernstein, Daniel Q Huang, et al.
Gastroenterology|March 11, 2026
Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseFasiha Kanwal, Fernando Bril, Vincent Wai-Sun Wong, et al.
Gastroenterology|October 4, 2021
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver DiseaseFasiha Kanwal, Jay H Shubrook, Leon A Adams, et al.
World Journal of Gastroenterology|August 14, 2025
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virusAna N Hyatt, Sai K Kuchana, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics|December 29, 2023
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United StatesSamer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, et al.
The Journal of Pediatrics|September 19, 2017
Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic BoysJulia Wattacheril, Joel E Lavine, Naga P Chalasani, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare DiseasesAdam Wanner, Stephen C Groft, J Russell Teagarden, et al.
Pageof 64